Skip to main content

Table 1 Baseline characteristics of patients with baseline and post-baseline data

From: Construct validity of 2 measures to assess reasons for antipsychotic discontinuation and continuation from patients’ and clinicians’ perspectives in a clinical trial

 

Baseline patient population

All patients with post-baseline RAD data

 

(N = 596)

(N = 481)

Age, mean (SD)

41.8 (11.0)

41.8 (11.0)

Male,%

62.2

61.5

Race,%

  

African-American

44.8

44.1

Caucasian

44.1

43.9

Other

11.1

12.1

Hospitalizations in Past Year,%

39.4

38.5

Diagnosis,%

  

Schizophrenia

75.5

76.9

Schizoaffective – Bipolar

15.8

14.1

Schizoaffective – Depressive

8.7

8.9

Living Situation,%

57.6

56.5

No/Limited Supervision

  

PANSS Total, mean (SD)

92.5 (13.8)

92.3 (13.3)

MADRS Total, mean (SD)

16.2 (9.2)

16.0 (9.3)

CGI-Severity, mean (SD)

4.6 (0.6)

4.6 (0.6)

  1. No statistically significant (p < .05) differences were found between patients with and without a post-baseline RAD measurement.
  2. CGI = Clinical Global Impressions; MADRS = Montgomery-Asberg Depression Rating Scale; N = number of patients; PANSS = Positive and Negative Syndrome Scale; RAD = Reasons for Antipsychotic Discontinuation/Continuation; SD = standard deviation.